Externally Led Patient-Focused Drug Development (EL-PFDD) Meeting on Infertility and IVF


26 March
2026

10am to
3:30pm

Join Us
Virtually

Externally Led Patient-Focused Drug Development (EL-PFDD) Meeting on Infertility and IVF

26 March 2026,
10am to 3:30pm

Join Us Virtually

Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


Douglas Fair, MD, MS, FAAP

Douglas Fair, MD, MS, FAAP

Douglas Fair, MD, MS, FAAP, is board-certified in pediatrics and pediatric hematology and oncology. He is an Associate Professor in the Division of Pediatric Hematology/Oncology at the University of Utah and treats solid tumor patients at Primary Children’s Hospital and the Huntsman Cancer Institute.

Dr. Fair received his medical degree from Albany Medical College in upstate New York, completed his Pediatric residency at UT Southwestern in Austin at Dell Children´s Hospital, and his pediatric hematology and oncology fellowship at the University of Utah. He also has a Master of Science degree from the University of Utah.

Dr. Fair serves as the program director for the Primary Children’s Hospital Sarcoma and Musculoskeletal Tumor Program. He also is the founder and medical director of the Primary Children’s Hospital Childhood and Adolescent and Young Adult (AYA) Cancer Survivorship Program. He is the medical director of the Huntsman Cancer Institute AYA Program and serves as co-medical director of the Huntsman Intermountain Adolescent and Young Adult Program (HIAYA). He also co-founded and serves as the associate medical director for the Primary Children’s Hospital Supportive Oncology for Adolescents and Pediatrics Program (SOAP). He is the founder and co-medical director of the Univerisity of Utah Oncofertility Program, the Primary Children’s Hospital Oncofertility Program, and the Huntsman Cancer Institute Oncofertility Program.

At the nation level Dr. Fair serves on numerous committees and steering committees. These include serving on the steering committees for the Rare Tumor Group and the Soft Tissue Sarcoma Groups within the Children’s Oncology Group (COG). He is a member of the AYA Responsible Investigator (RI) Group within COG. He serves on the National Comprehensive Cancer Network (NCCN) AYA Guideline Committee. He is also a member of the Oncofertility Consortium and a member of the Pediatric Iniative Network (PIN).